The Ministry of Commerce, in collaboration with the People's Government of Jiangsu Province, has jointly unveiled the "Plan for the Open and Innovative Development of the Full Biopharmaceutical Industry Chain in the China (Jiangsu) Pilot Free Trade Zone." This ambitious plan outlines multiple financing avenues to bolster qualified biopharmaceutical innovators, notably through listing on the ChiNext, STAR Market, and Beijing Stock Exchange, as well as on the New Third Board and via the issuance of corporate credit bonds. Furthermore, it promotes the establishment of sub-funds dedicated to biopharmaceutical investments by industrial investment funds and venture capital firms. Additionally, the plan supports the issuance of infrastructure REITs and real estate trust asset-backed notes for biopharmaceutical industrial park projects, while also establishing a market-oriented risk insurance compensation mechanism aimed at facilitating breakthroughs in biopharmaceutical research and development.